Showing results (761-770 of 1,873) with videos related to
Sort By:
Pageof 188
Pulmonary Pharmacology & Therapeutics|November 11, 2008
A role for MC3R in modulating lung inflammationStephen J Getting, Yanira Riffo-Vasquez, Simon Pitchford, et al.Pulmonary Pharmacology & Therapeutics|January 27, 2009
Effect of mode of administration on guaifenesin pharmacokinetics and expectorant action in the rat modelLeonid Kagan, Eran Lavy, Amnon HoffmanPulmonary Pharmacology & Therapeutics|January 13, 2009
Semantics and types of coughKian Fan Chung, Don Bolser, Paul Davenport, et al.Pulmonary Pharmacology & Therapeutics|January 13, 2009
Airway smooth muscle contraction - perspectives on past, present and futureH W MitchellPulmonary Pharmacology & Therapeutics|January 14, 2009
Risk factors for asthma severity among emergency rooms attendees, PalestineHamzeh Al Zabadi, Nuha El SharifPulmonary Pharmacology & Therapeutics|September 30, 2022
May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?Ralph Brattsand, Olof SelroosPulmonary Pharmacology & Therapeutics|November 26, 2023
Cefepime pharmacokinetics in adult extracorporeal membrane oxygenation patientsLily Zheng, Mohammad H Alshaer, Charles Peloquin, et al.Pulmonary Pharmacology & Therapeutics|November 15, 2023
Tyvaso DPI: Drug-device characteristics and patient clinical considerationsColleen McEvoy, Rahul Argula, Sandeep Sahay, et al.Pulmonary Pharmacology & Therapeutics|November 15, 2023
The wonders of stem cells therapeutic application towards chronic obstructive pulmonary diseaseAkram Tayanloo-Beik, Shayesteh Kokabi Hamidpour, Mohaddese Chaharbor, et al.Pulmonary Pharmacology & Therapeutics|January 8, 2024
Tanshinone IIA alleviates bleomycin-induced pulmonary fibrosis by inhibiting Zbtb16Huijuan Zhang, Jianli Qiu, Qianyi Zhao, et al.Pageof 188